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June Supplement 201094S AbstractsObjectives: To evaluate the outcomes of carotid artery
stenting (CAS) vs historical open surgery (OS) controls in
patients with radiation-induced carotid stenosis (RICS),
with or without prior radical neck dissection (RND).
Methods: We retrospectively reviewed 55 patients
treated for 68 RICS from a group of 5, 824 patients who had
carotid interventions from 1992-2009. Twenty-six patients
(29 arteries) were treated with CAS and 29 patients (39
arteries) with OS. CAS was performed using embolic protec-
tion as part of a prospective registry since 2003, after which
only 3 patients had OS for RICS. Patients were analyzed
according to their RND status ( or) for the end-points of
mortality, stroke/TIA, cranial nerve injury, wound complica-
tion, restenosis (50%) and reintervention.
Results:Clinical and anatomical characteristics were sim-
ilar between groups. There were no early deaths. At 30-days,
OSwas associatedwith stroke/TIA in1patient (2.5%), cranial
nerve injury in 3 (8%), and wound complications in 7 (18%),
with mean length of stay (LOS) of 16  33 days. Wound
complicationsweremore common inRNDpatients (36% vs
6%, p  0.01). In the CAS group, 2 patients (7%) had
stroke/TIA at 30-days, but none had cranial nerve injury or
wound complication, with mean LOS was 3  4 days (p 
0.01). Median follow-up was 26 months. OS was associated
with higher freedom from stroke/TIA at 3-years (100% vs
86  9%) and lower rates of restenosis (7% vs 32%) and
reintervention (0% vs 18%) than CAS (p 0.05). The higher
rate of restenosis and reintervention for CAS was observed
among both RND (33% and 17% vs 0% and 0%) and RND-
patients (25% and 25 % vs 10% and 0%).
Conclusions: CAS for RICS had shorter LOS, no
cranial nerve injury or wound complication, and similar
early stroke rate as compared to OS. However, the higher
rates of late neurologic events, restenosis and reinterven-
tion during follow-up may offset the early benefits of CAS
in patients who are candidates for OS.
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Changing Trends in Assessment and Management of
Carotid Body Tumors: A 35-Year Experience
Efthimios D. Avgerinos1, Elias Brountzos2, Andreas M.
Lazaris1, Anastasios Papapetrou1, Nikolas Ptohis2, Tri-
antafilos Giannakopoulos1, Christos Liapis1. 1Department
of Vascular Surgery, Attikon University Hospital, Athens
Medical School, Chaidari, Athens, Greece; 22nd Depart-
ment of Radiology, Attikon University Hospital, Athens
Medical School, Chaidari, Athens, GreeceObjectives: Conventional and modern functional im-
aging techniques, genetic screening and evolving surgical/
endovascular techniques accompanied (or not) with radio-
therapy and/or chemotherapy have altered the overall
management of carotid body tumors (CBT).We review our
35-year experience, emphasizing on the changing trends in
the evaluation and treatment of CBT.
Methods: Medical records of 27 patients diagnosed
with a CBT between 1975 and 2009 were retrospectively
reviewed.
Results: Our study cohort consisted of 8 Shamblin I,
10 II, and 9 III (3 with intracranial spread) tumors. During
the early years (18 cases up to 1998) CT-scanning and
angiography were used for diagnosis, while surgical exci-
sion following selective embolization, when indicated, was
standard care. Local lymph node invasion established the
diagnosis of malignancy in two patients. One of these
patients developed distal metastases 3 years later. After
2000 (9 cases), patients were co-evaluated by DOTA-
octreotide andMR imaging (3D TOFMRA), while also by
genetic screening when necessary. Among those, two sis-
ters with CBT and free parental history were assessed and
operated. A missense mutation Y114C, in exon-4 of the
SDHD gene, in the unaffected father and both affected
sisters was identified. Four other patients with large CBT
were pretreated via a covered stent placement in the “tumor
supplying” external carotid artery. One of these patients
required further neo-adjuvant chemotherapy which per-
mitted successful tumor resection.
Conclusions: Improved understanding of the patho-
physiology of CBT along with contemporary imaging,
surgical techniques and radio- chemotherapies have vastly
improved outcomes for patients. Surgeon and institutional
competence are critical in achieving maximal outcomes.
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Objectives: Flow reversal for cerebral protection dur-
ing carotid angioplasty and stenting introduces a variety of
new imaging concepts and techniques that maybe associ-
ated with a significant learning curve to achieve optimal
outcomes. The aim of the study was to evaluate the learning
curve with the use of this new reverse flow technology.
Methods: Data were prospectively collected as part of
the EMPiRE study group evaluating the GORE Flow
Reversal System (WL Gore, Flagstaff, AZ) and divided into
4 groups. Group I (n  62) was the initial 2 training cases
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142) included the next 3-10 procedures, group III (n 
74) included the next 11-20 procedures, and group IV
(n  76) included  21 procedures. Variables evaluated
include procedure time, total flow reversal time, fluoro-
scopic time, contrast volume, hospital length of stay, and
any major adverse events (death, stroke, transient ischemic
events and myocardial infarction through 30 days). P-
values based on mixed effects linear model.
Results: Procedure time (minutes) in each group re-
spectively was 105.4  38.6, 92.2  42.8, 80.5  37.9,
and 57.5 20.7 (p 0.001). Flow reversal time (minutes)
was 18.4  13.4, 16.1  8.9, 15  9.7, and 11.5  7.7
(p  0.0028). Fluoro time (minutes) was 25.5  15.2,
23.3 17.2, 19 7.9, and 15 6.2 (p 0.23). Contrast
volume (mL) was 160.3  86.8, 163.6  99.1, 126.6 
62.8, 99.7  44.9 (p  0.017). Length of stay (days) was
2 1.6, 2.2 2.9, 1.7 2.3, and 1.8 1.7 (p 0.357).
Major adverse events (%) in each group was 1.61, 4.23,
6.76, and 2.63 (p  0.4).
Conclusions: Despite a significant decrease in the total
procedure and flow reversal times, with increased experi-
ence, there was no impact upon clinical outcomes, estab-
lishing the safety of this cerebral protection strategy even
among early users.
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Open AAA Repair Is Feasible and Can Be Done With
Excellent Results in Octogenarians
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son1. 1University of Pennsylvania, Philadelphia, PA; 2Coo-
per University, Camden, NJ
Objectives: To determine the feasibility of open AAA
repair in octogenarians during the time of multiple comm-
ericially-available endografts where only proximal aneu-
rysms or the most challenging anatomy is not stented.
Methods: A retrospective review was performed.
Records for open AAA repair were obtained in patients over
80 from 2003-2009.
Results: Sixty-five patients (27M) had a median age of
82. Mean AAA size was 6.7cm. Morphology consisted of
Type IV-19, Suprarenal-14, Pararenal-19, Infrarenal-13. A
tube graft was used in 58 and the left renal was reimplanted
in 32. Fifty-two required a suprarenal or supraceliac clamp
(mean ischemic time-22 minutes). Mean EBL was 1800cc.
Mortality was 6% at 30 days.Median ICU and hospital LOS
were 3 and 9 days, respectively with 61% of patients dis-
charged directly home. Overall, 28 patients suffered some
type of complication, 25% being an arrhythmia. Six patients
developed acute renal failure although no patients pro-
gressed to dialysis. Mean serum creatinine preoperativelywas 1.3 and at discharge 1.5. Only one patient developed
bowel necrosis (sigmoid colon) requiring resection. Fol-
low-up ranged from 1-81months. Survival is demonstrated
in the Figure.
Conclusions: With an increasing population of elderly
patients, vascular surgeons are continually confronted with
patients over 80 years of age. Our patients consisted of
those not amenable to EVAR for anatomic reasons. Despite
a predominance of proximal aneurysms our results demon-
strate excellent morbidity and mortality. Thus, open AAA
can be done safely in octogenarians and age alone should
not exclude repair.
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Carotid Artery Disease: Risk Factor Analysis in a Co-
hort of 3.9 Million Individuals
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Objectives: To develop a risk stratification tool that
permits the identification of patients with clinically impor-
tant carotid artery stenosis (CAS) for medical or surgical
intervention.
Methods: In 2003-2008, demographics and risk fac-
tors were collected from a uniquely large patient popula-
tion (3.9million), who underwent ultrasound screening for
CAS by Life Line screening. Using multivariable logistic
regression analysis, we identified risk factors and developed
a scoring system to predict the presence of CAS (50%).
